Fundraising Fox

Matthew Kapusta

Executive at Uniqure

Greater Boston

Find your path to Matthew

301 people in our graph share verified history with Matthew — schools, employers, funds. One of them is your warm intro.

Drew BurdonunlockedMatthew: together at Smith+Nephew (2009–2011)
×2Matthew: together at NYU Stern School of Business
×8Matthew: together at Wellsfargo
Matthew: together at Collins Stewart

About

Matthew Kapusta is Chief Executive Officer of uniQure, a gene therapy company, having joined the organization as Chief Financial Officer in January 2015; he also serves as a board member at Genezen. His earlier career includes senior roles at AngioDynamics and Smith & Nephew Orthopaedics, along with more than a decade in healthcare investment banking at firms including Collins Stewart, Wells Fargo Securities, Robertson Stephens, and PaineWebber. He holds an MBA from New York University's Stern School of Business and a BBA from the University of Michigan's Ross School of Business, and earned his CPA license in 1996 while at Ernst & Young.

Executive at Uniqure

Intro paths

→

In turn, Matthew can intro founders to Uniqure's investors below.

Uniqure's investors · 3

Advent Life SciencesLondonForesite CapitalWest HollywoodHEALTHCARE ROYALTY PARTNERSNew York

Experience

  1. GenezenBoard Membercurrent2024 — presentIndianapolis, Indiana, United States
  2. Alliance of Regenerative Medicine (ARM)Board Membercurrent2023 — present
  3. uniQureChief Executive Officercurrent2016 — presentGreater Boston
  4. uniQureChief Financial Officer2014 — 2016Greater Boston
  5. Decibel TherapeuticsBoard Member2023Boston, Massachusetts, United States
  6. AngioDynamicsSenior Vice President, Business Development2011 — 2015Latham, NY
  7. Smith & NephewVice President, Global Financial Planning, Analysis and Strategy2009 — 2011
  8. Collins StewartManaging Director, Healthcare Investment Banking2005 — 2009
  9. Wells Fargo SecuritiesVice President, Healthcare Investment Banking2002 — 2005
  10. Robertson Stephens LLCSenior Associate, Healthcare Investment Banking2000 — 2002
  11. PaineWebberInvestment Banker1999 — 2000

Skills & more

Business Development17Analysis8Biotechnology4Competitive Analysis1Business Strategy18Corporate Development16Investment Banking15Cross-functional Team Leadership4Finance3Healthcare8Financial Modeling2Due Diligence2
+12 moreManagementInvestmentsLeadershipMergersMedical DevicesMergers & AcquisitionsMarket DevelopmentNew Business DevelopmentStrategic PlanningStrategyProduct LaunchStart-ups
  • Certified Public Accountant — AICPA

From Matthew's professional profile.

Frequently asked questions

Who is Matthew Kapusta?
Matthew Kapusta is Chief Executive Officer of uniQure, a gene therapy company, having joined the organization as Chief Financial Officer in January 2015; he also serves as a board member at Genezen. His earlier career includes senior roles at AngioDynamics and Smith & Nephew Orthopaedics, along with more than a decade in healthcare investment banking at firms including Collins Stewart, Wells Fargo Securities, Robertson Stephens, and PaineWebber. He holds an MBA from New York University's Stern School of Business and a BBA from the University of Michigan's Ross School of Business, and earned his CPA license in 1996 while at Ernst & Young.
Where did Matthew Kapusta go to school?
Matthew Kapusta studied at NYU Stern School of Business (MBA, Finance, Business Management); University of Michigan - Stephen M. Ross School of Business (BBA, Finance, Accounting).

Same school

Also attended NYU Stern School of Business820

Luna SchmidInvestor at GV (Google Ventures)Kaz TeradaVenture Advisor at Monta Vista CapitalNeil FongManaging Director Asia at Burda Principal InvestmentsMax WechterSenior Director of AI at Lerer HippeauKrupa VankayalaPartner, People & HR at Sapphire VenturesDanny BrowneInvestor at FJ Labs

+ 814 more

Also attended University of Michigan - Stephen M. Ross School of Business541

Alexandra FarmerPrincipal at Intel Capital, North AmericaTige SavageCo-founder at RevolutionWendy XiaoPartner at NorthzoneRob LawrenceSenior Finance Associate at GreycroftHyun KooPartner at March Capital PartnersRichard GuVice President at March Capital Partners

+ 535 more

Shared employers

Also worked at uniQure6

Mariette van der VeldenPartner at Curie CapitalSana BenmahriaHead of Technology at WaterlandDavid SchafferProfessor of Bioengineering; Co-founder, 4D Molecular and Axent Biosciences (Faculty Advisor) at UC Berkeley SkydeckWill LewisFounder at InsmedDavid MeekChief Executive Officer at Bluebird BioEva van RooijenCEO & Co-Founder at Foveo fertility

Also worked at Decibel Therapeutics6

John KeiltyVenture Partner at Third Rock VenturesChristina IsacsonPartner at Lightstone VenturesDr. Jens EcksteinAdvisor at Apollo Health VenturesElisabeth LeidermanExecutive Officer at Dewpoint TherapeuticsPaula CobbExecutive Officer at Affinia TherapeuticsErik LarsenSenior Vice President, Clinical Development & Customer Success at Sondehealth

Also worked at AngioDynamics15

Sean MorrisGeneral Partner at Cultivation CapitalBenjamin M. KingVice President at Spire Capital PartnersShaun O'NeilExecutive Officer at Lucid DiagnosticsMichael GreinerChief Financial Officer at Extreme ReachPeter GrahamChief Legal Officer at ADC Therapeutics SAChad CampbellSenior Vice President and General Manager, Oncology and Interventional Devices at AngioDynamics

+ 9 more

Also worked at Collins Stewart7

Raghu MadabushiInvestment Director at Samsung Catalyst FundWilliam LamondInvestment Director - Jersey at OakglenCharlotte LarbalestierHead of Compliance - Jersey at OakglenScott CullinaneFinancial Adviser at OakglenBrad DunstanCo-Chief Investment Officer at NZ Super FundMatthew Le MaitreFounder at Seeing Systems

+ 1 more